Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer

Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer

Abstract Lung cancer is a leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) being the most common histological type. Owing to the limited therapeutic efficacy and side effects of currently available therapies for NSCLC, it is necessary to identify novel the...

Full description

Bibliographic Details
Main Authors: Yanqin Luo, Jingyang Li, Peng Yu, Jiayi Sun, Yingfan Hu, Xianli Meng, Li Xiang
Format: Article
Language:English
Published: Nature Publishing Group 2022-04-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-022-00982-x

Internet

https://doi.org/10.1038/s41420-022-00982-x

Similar Items